Napredna pretraga

Pregled bibliografske jedinice broj: 417388

The impact of molecular diagnosis on management and counseling in prevalent Mendelian muscle and nerve disorders


Canki-Klain, Nina
The impact of molecular diagnosis on management and counseling in prevalent Mendelian muscle and nerve disorders // NEUROMEDITERRANEAN 10
Durres: "EDLORA", 2009. str. 14-14 (pozvano predavanje, međunarodna recenzija, sažetak, znanstveni)


Naslov
The impact of molecular diagnosis on management and counseling in prevalent Mendelian muscle and nerve disorders

Autori
Canki-Klain, Nina

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
NEUROMEDITERRANEAN 10 / - Durres : "EDLORA", 2009, 14-14

ISBN
978-99956-13-27-3

Skup
NEUROMEDITERRANEAN 10

Mjesto i datum
Drač, Albanija, 09.05.2009

Vrsta sudjelovanja
Pozvano predavanje

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Positional cloning; Dystrophin Associated Proteins (DAS); Unstable expanding trinucleotide repeats mutations; .Human genome project; managgement; counselling

Sažetak
A rapid increase in our understanding of molecular mechanisms behind many of debilitating genetic disorders is largely due to advances in recombinant DNA technology since 1980s and early 1990s. Progress in molecular diagnosis of monogenic diseases in neurology is especially due to: 1.Positional cloning and discovery of dystrophin gene (1986) and its defective protein (1987) in DMD/BMD ; 2.Discovery of Dystrophin Associated Proteins (DAS) ; 3. Unstable expanding trinucleotide repeats mutations and 4.Human genome project. The discovery of dystrophin gene and its defective protein in Duchenne and Becker muscular dystrophy (DMD/BMD) was crucial in two ways: it showed the potency of positional cloning's strategy and gave the new tool for diagnosis - protein analysis (primary or secondary reduction of proteins directly or indirectly associated with dystrophin). Combined genetic and protein analysis represent the new tools for diagnosis ; allow carrier testing and prenatal diagnosis if required. Application of these tools has discovered a big genetic heterogeneity of many muscle and nerve disorders. Considerable clinical heterogeneity of the same disease can be explained by the occurrence of different mutations of a single gene. On the other hand, similar clinical features can be caused by different genes .These clinical and genetic heterogeneity constitute a major diagnostic trap, and here fairly complex investigations may be necessary to provide a precise diagnosis before any genetic counselling can be provided. Therefore the rational diagnostic approach to these disorders should be multidisciplinary with expertise in interpretation of complex diagnostic process. In addition practical aspect of the exact genetic diagnosis is represented by appropriate patient’ s management and genetic counselling.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekt / tema
108-0000000-3435 - Genetika, priroda i epidemiologija značajnijih živčanih i mišićnih bolesti (ŽMB) (Nina Canki-Klain, )

Ustanove
Medicinski fakultet, Zagreb

Autor s matičnim brojem:
Nina Canki-Klain, (216671)